Evidence map›Paper›PMID 30325506›Full record

ArticleThe Laryngoscope2019

Phosphorylation of the glucocorticoid receptor alters SMAD signaling in vocal fold fibroblasts.

Shigeyuki Mukudai, Nao Hiwatashi, Renjie Bing, Michael Garabedian, Ryan C Branski

Open access · greenAbstract read
In one paragraph

Article in The Laryngoscope, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Role of TGF-β1/SMADs signalling pathway in resveratrol-induced reduction of extracellular matrix deposition by dexamethasone-treated human trabecular meshwork cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shigeyuki MukudaiFrom the Department of Otolaryngology-Head and Neck Surgery , NYU Voice Center, New York, New York, U.S.A.
Nao HiwatashiFrom the Department of Otolaryngology-Head and Neck Surgery , NYU Voice Center, New York, New York, U.S.A.
Renjie BingFrom the Department of Otolaryngology-Head and Neck Surgery , NYU Voice Center, New York, New York, U.S.A.
Michael Garabedianthe Department of Microbiology , New York University School of Medicine, New York, New York, U.S.A.
Ryan C BranskiFrom the Department of Otolaryngology-Head and Neck Surgery , NYU Voice Center, New York, New York, U.S.A.ORCID 0000-0003-1190-9036
New York University · US

Funding

Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal foldsR01DC017397 · NIDCD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BRANSKI, RYAN COMFORT · 2018 to 2022
$2.6M
Optimal RNA-based therapeutics for vocal fold injury and fibrosisR01DC013277 · NIDCD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BRANSKI, RYAN COMFORT · 2014 to 2018
$2.3M
National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) DC DC017397National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) RO1 DC013277NIDCD NIH HHS R01 DC013277NIDCD NIH HHS R01 DC017397
6 · The paper itself

Abstract

objectives/hypothesisDirect glucocorticoid (GC) injection for vocal fold (VF) scarring has evolved as a therapeutic strategy, but the mechanisms underlying the antifibrotic effects remain unclear. GCs act via the glucocorticoid receptor (GR), which is phosphorylated at multiple serine residues in a hormone-dependent manner to affect bioactivity. We hypothesize that GCs regulate SMAD signaling via GR phosphorylation in vocal fold fibroblasts (VFFs). STUDY

designIn vitro.

methodsHuman VFFs were treated with dexamethasone (DM; 10

resultsTotal GR and Ser

conclusionDM regulated TGF-β1 signaling via altered SMAD3 and SMAD7 expression. This response was associated with altered GR phosphorylation. These findings provide insight into the mechanisms of steroidal effects on vocal fold repair; ultimately, we seek to enhance therapeutic strategies for these challenging patients. LEVEL OF EVIDENCE: NA Laryngoscope, 129:E187-E193, 2019.

Indexed as

ActinsCell LineDexamethasoneElectrophoresis, Polyacrylamide GelFibroblastsHumansImmunohistochemistryMifepristonePhosphorylationPolymerase Chain ReactionReceptors, GlucocorticoidRNA, MessengerSignal TransductionSmad3 ProteinSmad7 ProteinTransforming Growth Factor betaACTA2 protein, humanActinsDexamethasoneMifepristoneReceptors, GlucocorticoidRNA, MessengerSmad3 ProteinSMAD3 protein, humanSmad7 ProteinSMAD7 protein, humanTransforming Growth Factor betaglucocorticoidglucocorticoid receptorphosphorylationtransforming growth factor-βVocal foldvoice

Identifiers

PMID30325506
PMCPMC6467698
OpenAlexW2896233204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.